We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1/2-mediated activation of caspase-8-/caspase-3-dependent pathway.
- Authors
Ying, Tsung-Ho; Yang, Shun-Fa; Tsai, Su-Ju; Hsieh, Shu-Ching; Huang, Yi-Chang; Bau, Da-Tian; Hsieh, Yi-Hsien
- Abstract
Fisetin is a naturally occurring flavonoid that has been reported to inhibit the proliferation and to induce apoptotic cell death in several tumor cells. However, the apoptosis-inducing effect of fisetin on tumor cell lines was investigated besides HeLa cells. In this study, we found that fisetin induced apoptosis of HeLa cells in a dose- and time-dependent manner, as evidenced by nuclear staining of 4′-6-Diamidino-2-phenylindole (DAPI), flow cytometry assay, and Annexin-V/PI double-labeling. In addition, fisetin triggered the activations of caspases-3 and -8 and the cleavages of poly (ADP-ribose) polymerase, resulting in apoptosis induction. Moreover, treatment of HeLa cells with fisetin induced a sustained activation of the phosphorylation of ERK1/2, and inhibition of ERK1/2 by PD98059 (MEK1/2 inhibitor) or transfection with the mutant ERK1/2 expression vector significantly abolished the fisetin-induced apoptosis through the activation of caspase-8/-3 pathway. The in vivo xenograft mice experiments revealed that fisetin significantly reduced tumor growth in mice with HeLa tumor xenografts. In conclusion, our results indicated that fisetin exhibited anti-cancer effect and induced apoptosis in HeLa cell lines both in vitro and in vivo.
- Subjects
CANCER cells; CELL death; APOPTOSIS; WOMEN'S health; CERVICAL cancer
- Publication
Archives of Toxicology, 2012, Vol 86, Issue 2, p263
- ISSN
0340-5761
- Publication type
Article
- DOI
10.1007/s00204-011-0754-6